Our data on survival analysis with GEPIA2 and the Kaplan Meier plotter indicated that lung adenocarcinoma patients with high ALDOA expression or genetic alteration have a poor overall survival prognosis. This evidence concerns the gene ALDOA and lung adenocarcinoma.